Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe footer's site revision changes from v3.7.1 to v3.7.2. The study page remains an access-denied 403 screen.SummaryDifference0.2%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page remains a 403 Forbidden error screen, with no study record content displayed.SummaryDifference0.2%

- Check28 days agoChange DetectedRemoval of the 403 Forbidden error page and its HTML wrapper, eliminating the access-denied screen. The page is left with its standard layout rather than showing a 403 error.SummaryDifference0.5%

- Check34 days agoChange DetectedThe study page now shows a 403 Forbidden error screen, blocking access to the study record while the site layout remains visible.SummaryDifference19%

- Check56 days agoChange DetectedA new revision tag v3.6.6 appears, replacing the previous v3.6.5. This reflects a small backend/content update to the page’s publication version.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.